4.5 Review

Pulmonary Hypertension in Heart Failure

期刊

JOURNAL OF CARDIAC FAILURE
卷 16, 期 6, 页码 461-474

出版社

CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
DOI: 10.1016/j.cardfail.2010.01.003

关键词

Heart failure; pulmonary hypertension; pulmonary reversibility testing; pulmonary vascular resistance; left ventricular assist device; heart transplant

向作者/读者索取更多资源

Background: Pulmonary hypertension occurs in 60% to 80% of patients with heart failure and is associated with high morbidity and mortality Methods and Results: Pulmonary artery pressure correlates with increased left ventricular end-diastolic pressure, Therefore. pulmonary hypertension is a common feature of heart failure with preserved as well as reduced systolic function Pulmonary hypertension is partially reversible with normalization of cardiac filling pressures Pulmonary vasculature remodeling and vasoconstriction create a second component. which does not reverse immediately, but has been shown to improve with vasoactive drugs and especially with left ventricular assist devices Conclusion: Many drugs used for idiopathic pulmonary arterial hypertension ale being considered as treatment options for heart failure-related pulmonary hypertension This is of particular significance in the heart transplant population Randomized clinical trials with in targeting heart failure patients with elevated pulmonary artery pressure would be justified (J Cardiac Fail 2010.16 461-474)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据